FDA 483 - Pan Medical Ltd. - April 04, 2016

The provided content outlines the fundamental regulatory framework for FDA Form 483, a critical report generated during facility inspections. It specifically cites Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21 USC 374(b)) as the legal basis. This section mandates that an inspecting officer document any objectionable conditions or practices identified within an establishment, which may indicate that a product (food, drug, device, or cosmetic) is adulterated, contaminated, or prepared under insanitary conditions, potentially rendering it injurious to health. The report serves to ensure compliance with FDA regulations or to assist inspected firms. The document itself is explicitly identified as records released on May 30, 2019, under FOIA request 2018-6807. Importantly, the provided text does not contain specific details regarding a company name, inspection dates, particular violations or issues, or any mandated corrective actions from a specific inspection. Instead, it offers a general overview of the legal and procedural context surrounding FDA Form 483.